Sesamol treatment reduces plasma cholesterol and triacylglycerol levels in mouse models of acute and chronic hyperlipidemia

Lipids

Volumn 48, Issue 6, 2013, Pages 633-638

  Kumar, Nitesh ^a   Mudgal, Jayesh ^a   Parihar, Vipan K ^a   Nayak, Pawan G ^a   Kutty, N Gopalan ^a   Rao, C Mallikarjuna ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

High fat with high fructose diet model; Hyperlipidemia; Hypertriglyceridemia; Sesamol; Tyloxapol

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; NICOTINIC ACID; SESAMOL; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; TYLOXAPOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; EXCRETION; HYPERLIPIDEMIA; INTESTINE ABSORPTION; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ACUTE DISEASE; ANIMALS; ANTIOXIDANTS; BENZODIOXOLES; BODY WEIGHT; CHOLESTEROL; CHRONIC DISEASE; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; MALE; MICE; PHENOLS; SESAMUM; TRIGLYCERIDES;

ANIMALIA; MUS; SESAMUM INDICUM;

EID: 84878574141     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-013-3778-2     Document Type: Article

References (21)

1. Chen PR, Chien KL, Su TC, Chang CJ, Liu TL, Cheng H, Tsai C (2005) Dietary sesame reduces serum cholesterol and enhances antioxidant capacity in hypercholesterolemia. Nutr Res 25(6):559-567
2. Kiran K, Asad M (2008) Wound healing activity of Sesamum indicum L. seed and oil in rats. Indian J Exp Biol 46(11):777-782
3. Shenoy RR, Sudheendra AT, Nayak PG, Paul P, Kutty NG, Rao CM (2010) Normal and delayed wound healing is improved by sesamol, an active constituent of Sesamum indicum (L.) in albino rats. J Ethnopharmacol 133(2):608-612
4. Wichitsranoi J, Weerapreeyakul N, Boonsiri P, Settasatian C, Settasatian N, Komanasin N, Sirijaichinkul S, Teerajetgul Y, Rangkadilok N, Leelayuwat N (2011) Antihypertensive and antioxidant effects of dietary black sesame meal in pre-hypertensive humans. Nutr J 9(10):82
5. Biswas A, Dhar P, Ghosh S (2010) Antihyperlipidemic effect of sesame (Sesamum indicum L.) protein isolate in rats fed a normal and high cholesterol diet. J Food Sci 75(9):274-279
6. Kang MH, Naito M, Tsujihara N, Osawa T (1998) Sesamolin inhibits lipid peroxidation in rat liver and kidney. J Nutr 128(6):1018-1022
7. Parihar VK, Prabhakar KR, Veerapur VP, Kumar MS, Rosi Reddy Y, Joshi R, Unnikrishnan MK, Rao CM (2006) Effect of sesamol on radiation-induced cytotoxicity in Swiss albino mice. Mutat Res 611(1-2):9-16
8. Ying Z, Kherada N, Kampfrath T, Mihai G, Simonetti O, Desikan R, Selvendiran K, Sun Q, Ziouzenkova O, Pathasarthy S, Rajagopalan S (2010) A modified sesamol derivative inhibits progression of atherosclerosis. Arterioscler Thromb Vasc Biol 31(3):536-542
9. Toyoda-Ono Y, Yoshimura M, Nakai M, Fukui Y, Asami S, Shibata H, Kiso Y, Ikeda I (2007) Suppression of postprandial hypertriglyceridemia in rats and mice by oolong tea polymerized polyphenols. Biosci Biotechnol Biochem 71(4):971-976
10. Xie W, Xing D, Zhao Y, Su H, Meng Z, Chen Y, Du L (2005) A new tactic to treat postprandial hyperlipidemia in diabetic rats with gastroparesis by improving gastrointestinal transit. Eur J Pharmacol 10(1-2):113-120
11. Silva RM, Santos FA, Maciel MA, Pinto AC, Rao VS (2001) Effect of trans-dehydrocrotonin, a 19-nor-clerodane diterpene from Croton cajucara on experimental hypertriglyceridaemia and hypercholesterolaemia induced by Triton WR 1339 (tyloxapol) in mice. Planta Med 67(8):763-765.Arbeeny MC, Edelstein D, Freedman SR, Eder AH (1980) Serum lipoproteins of diabetic rats fed a high cholesterol diet. Diabetes 29:774-777
12. Nampurath GK, Mathew SP, Khanna V, Zachariah RT, Kanji S, Chamallamudi MR (2008) Assessment of hypolipidaemic activity of three thiazolidin-4-ones in mice given high-fat diet and fructose. Chem Biol Interact 171(3):363-368
13. Ballinger A, Peikin SR (2002) Orlistat: its current status as an anti-obesity drug. Eur J Pharmacol 440(2-3):109-117
14. McClendon KS, Riche DM, Uwaifo GI (2009) Orlistat: current status in clinical therapeutics. Expert Opin Drug Saf 8(6):727-744
15. Kamanna VS, Kashyap ML (2000) Mechanism of action of niacin on lipoprotein metabolism. Curr Atheroscler Rep 2(1):36-46
16. Kourounakis AP, Victoratos P, Perulis N, Stefanou N, Jiangou M, Hadjipetrou L, Kourounakis PN (2002) Experimental hyperlipidemia and the effect of NSAIDs. Exp Mol Pathol 73:135-138
17. Schurr PE (2006) Triton - induced hyperlipidemia in rats as an animal model for screening hyperlipidemic drugs. Lipids 7:68-74
18. Bertges LC, MourãoJr CA, Souza JB, Antonio VCC (2010) Hyperlipidemia induced by Triton WR1339 (Tyloxapol) in Wistar rats. Rev Bras Cien Med Saúde 1(1):40-42
19. Moghadasian MH (2002) Experimental atherosclerosis: a historical overview. Life Sci 70(8):855-865
20. Sirato-Yasumoto S, Katsuta M, Okuyama Y, Takahashi Y, Ide T (2001) Effect of sesame seeds rich in sesamin and sesamolin on fatty acid oxidation in rat liver. J Agric Food Chem 49(5):2647-2651
21. Paget GE, Bernes JM (1961) Evaluation of drug activities, In: Lawrence DR, Bacharach AL (ed) Pharmacometrics, Academic Press New York: 1:161